Clinical Trial Update: Potential Role of n-3 Fatty Acids in the Treatment of NAFLD in Pediatric Patients [Phase 1, Phase 2]

View source ↗

Summary

A pediatric study is exploring the potential role of omega-3 fatty acids in treating nonalcoholic fatty liver disease, spanning Phase 1 and Phase 2 to evaluate …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: St. Justine's Hospital | Conditions: Non Alcoholic Fatty Liver Disease (NAFLD) | Phase 1, Phase 2 | Status: UNKNOWN